Hanim Sen

1.1k total citations
32 papers, 788 citations indexed

About

Hanim Sen is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Hanim Sen has authored 32 papers receiving a total of 788 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Surgery, 21 papers in Cardiology and Cardiovascular Medicine and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Hanim Sen's work include Coronary Interventions and Diagnostics (30 papers), Cardiac Valve Diseases and Treatments (15 papers) and Antiplatelet Therapy and Cardiovascular Diseases (9 papers). Hanim Sen is often cited by papers focused on Coronary Interventions and Diagnostics (30 papers), Cardiac Valve Diseases and Treatments (15 papers) and Antiplatelet Therapy and Cardiovascular Diseases (9 papers). Hanim Sen collaborates with scholars based in Netherlands, Greece and United Kingdom. Hanim Sen's co-authors include Clemens von Birgelen, Kenneth Tandjung, Marije M. Löwik, Gerard C.M. Linssen, Martin G. Stoel, Frits H.A.F. de Man, Mounir W.Z. Basalus, K. Gert van Houwelingen, J. W. Louwerenburg and Job van der Palen and has published in prestigious journals such as The Lancet, Journal of the American College of Cardiology and The American Journal of Cardiology.

In The Last Decade

Hanim Sen

32 papers receiving 780 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hanim Sen Netherlands	15	671	534	224	216	33	32	788
Rafael Cavalcante Netherlands	21	841 1.3×	755 1.4×	257 1.1×	429 2.0×	5 0.2×	63	1.1k
M. Neale Australia	9	204 0.3×	214 0.4×	289 1.3×	117 0.5×	9 0.3×	13	492
Mounir W.Z. Basalus Netherlands	14	671 1.0×	498 0.9×	247 1.1×	216 1.0×	1 0.0×	28	742
Paul Saunders United States	14	485 0.7×	541 1.0×	246 1.1×	26 0.1×	23 0.7×	55	810
Stefano Galli Italy	13	501 0.7×	416 0.8×	249 1.1×	265 1.2×		41	696
Walid Hassan Saudi Arabia	13	159 0.2×	346 0.6×	202 0.9×	59 0.3×	25 0.8×	48	568
Alessio Mattesini Italy	18	1.1k 1.7×	767 1.4×	554 2.5×	393 1.8×	2 0.1×	88	1.4k
Wail Nammas Finland	17	462 0.7×	616 1.2×	218 1.0×	194 0.9×		121	900
Refat Jabara United States	15	329 0.5×	257 0.5×	216 1.0×	121 0.6×		29	543
Thomas Helton United States	8	531 0.8×	475 0.9×	143 0.6×	123 0.6×	1 0.0×	21	657

Countries citing papers authored by Hanim Sen

Since Specialization

Citations

This map shows the geographic impact of Hanim Sen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanim Sen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanim Sen more than expected).

Fields of papers citing papers by Hanim Sen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanim Sen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanim Sen. The network helps show where Hanim Sen may publish in the future.

Co-authorship network of co-authors of Hanim Sen

This figure shows the co-authorship network connecting the top 25 collaborators of Hanim Sen. A scholar is included among the top collaborators of Hanim Sen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanim Sen. Hanim Sen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Birgelen, Clemens von, Marlies M. Kok, Naveed Sattar, et al.. (2018). “Silent” Diabetes and Clinical Outcome After Treatment With Contemporary Drug-Eluting Stents. JACC: Cardiovascular Interventions. 11(5). 448–459. 16 indexed citations

Kok, Marlies M., Liefke C. van der Heijden, Hanim Sen, et al.. (2016). Sex Difference in Chest Pain After Implantation of Newer Generation Coronary Drug-Eluting Stents. JACC: Cardiovascular Interventions. 9(6). 553–561. 10 indexed citations

Tandjung, Kenneth, Ming Kai Lam, Hanim Sen, et al.. (2016). Value of the SYNTAX score for periprocedural myocardial infarction according to WHO and the third universal definition of myocardial infarction: insights from the TWENTE trial. EuroIntervention. 12(4). 431–440. 5 indexed citations

Sen, Hanim, Ming Kai Lam, Marije M. Löwik, et al.. (2015). Clinical Events and Patient-Reported Chest Pain in All-Comers Treated With Resolute Integrity and Promus Element Stents. JACC: Cardiovascular Interventions. 8(7). 889–899. 34 indexed citations

Heijden, Liefke C. van der, Marlies M. Kok, Ming Kai Lam, et al.. (2015). Bifurcation treatment with novel, highly flexible drug-eluting coronary stents in all-comers: 2-year outcome in patients of the DUTCH PEERS trial. Clinical Research in Cardiology. 105(3). 206–215. 9 indexed citations

Lam, Ming Kai, Kenneth Tandjung, Hanim Sen, et al.. (2015). Coronary artery dominance and the risk of adverse clinical events following percutaneous coronary intervention: insights from the prospective, randomised TWENTE trial. EuroIntervention. 11(2). 180–187. 14 indexed citations

Löwik, Marije M., Ming Kai Lam, Hanim Sen, et al.. (2015). Safety of second-generation drug-eluting stents three years after randomised use in the TWENTE trial. EuroIntervention. 10(11). 1276–1279. 12 indexed citations

Birgelen, Clemens von, Ming Kai Lam, Liefke C. van der Heijden, et al.. (2014). TCT-588 2-Year Clinical Outcome of the Randomized, Multicenter DUTCH PEERS (TWENTE II) Trial, Comparing Cobalt-Chromium Zotarolimus-Eluting Resolute Integrity Stents and Platinum-Chromium Everolimus-Eluting Promus Element Stents in “All-Comer” Patients. Journal of the American College of Cardiology. 64(11). B171–B171. 1 indexed citations

Sen, Hanim, Ming Kai Lam, Kenneth Tandjung, et al.. (2014). Impact of previous coronary artery bypass surgery on clinical outcome after percutaneous interventions with second generation drug-eluting stents in TWENTE trial and Non-Enrolled TWENTE registry. International Journal of Cardiology. 176(3). 885–890. 8 indexed citations

10.

Sen, Hanim, et al.. (2014). The Comparative Evaluation of Treatment Outcomes in Pediatric Displaced Supracondylar Humerus Fractures Managed with either Open or Closed Reduction and Percutaneous Pinning. Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca. 81(6). 380–386. 9 indexed citations

11.

Lam, Ming Kai, Hanim Sen, K. Gert van Houwelingen, et al.. (2014). Three-year clinical outcome of patients with bifurcation treatment with second-generation Resolute and Xience V stents in the randomized TWENTE trial. American Heart Journal. 169(1). 69–77. 15 indexed citations

12.

Tandjung, Kenneth, Mounir W.Z. Basalus, Hanim Sen, et al.. (2013). Women treated with second‐generation zotarolimus‐eluting resolute stents and everolimus‐eluting xience V stents: insights from the gender‐stratified, randomized, controlled TWENTE trial. Catheterization and Cardiovascular Interventions. 82(3). 396–405. 5 indexed citations

13.

Tandjung, Kenneth, Hanim Sen, Ming Kai Lam, et al.. (2013). Clinical Outcome Following Stringent Discontinuation of Dual Antiplatelet Therapy After 12 Months in Real-World Patients Treated With Second-Generation Zotarolimus-Eluting Resolute and Everolimus-Eluting Xience V Stents. Journal of the American College of Cardiology. 61(24). 2406–2416. 56 indexed citations

14.

Birgelen, Clemens von, Kenneth Tandjung, Hanim Sen, et al.. (2012). TCT-47 Two-Year Clinical Outcome of the TWENTE Trial, a Randomized Controlled Trial Comparing Second-Generation Zotarolimus-Eluting Resolute Stents Versus Everolimus-Eluting Xience V Stents in Real-World Patients. Journal of the American College of Cardiology. 60(17). B15–B15. 4 indexed citations

15.

Birgelen, Clemens von, Mounir W.Z. Basalus, Kenneth Tandjung, et al.. (2012). A Randomized Controlled Trial in Second-Generation Zotarolimus-Eluting Resolute Stents Versus Everolimus-Eluting Xience V Stents in Real-World Patients. Journal of the American College of Cardiology. 59(15). 1350–1361. 184 indexed citations

16.

Man, Frits H.A.F. de, Kenneth Tandjung, Marc Hartmann, et al.. (2012). Usefulness and safety of the GuideLiner catheter to enhance intubation and support of guide catheters: insights from the Twente GuideLiner registry. EuroIntervention. 8(3). 336–344. 47 indexed citations

17.

Tandjung, Kenneth, K. Gert van Houwelingen, Hanneke Jansen, et al.. (2012). Comparison of Frequency of Periprocedural Myocardial Infarction in Patients With and Without Diabetes Mellitus to Those With Previously Unknown but Elevated Glycated Hemoglobin Levels (from the TWENTE Trial). The American Journal of Cardiology. 110(11). 1561–1567. 22 indexed citations

18.

Sen, Hanim, Kenneth Tandjung, Mounir W.Z. Basalus, et al.. (2012). Comparison of eligible non-enrolled patients and the randomised TWENTE trial population treated with Resolute and XIENCE V drug-eluting stents. EuroIntervention. 8(6). 664–671. 16 indexed citations

19.

Basalus, Mounir W.Z., Kenneth Tandjung, Hanim Sen, et al.. (2011). Scanning electron microscopic assessment of coating irregularities and their precursors in unexpanded durable polymer‐based drug‐eluting stents. Catheterization and Cardiovascular Interventions. 79(4). 644–653. 23 indexed citations

20.

Fall, Mamadou, et al.. (2010). Potential use of densified polymer-pastefill mixture as waste containment barrier materials. Waste Management. 30(12). 2570–2578. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact